18F]Fludeoxyglucose for injection (Fludeoxyglucosi (18F) solutio iniectabilis): sterile and bacterial endotoxine-free solution of 2-[18F] fluoro-2-deoxy-D-glucopyranose (2-[18F] fluoro-2-deoxy-D-glucose) for diagnostic use. The solution contains 18F- fluoride isotope, minimum 95% of the radioactivity in the form of 2-[18F] fluoro-2-deoxy-D-glucose and 2-[18F] fluoro-2-deoxy-D-mannose, with the 2-[18F] fluoro-2-deoxy-D-mannose fraction not more than 10% of the total radioactivity (Ph.Eur.). Activity: 400MBq-90GBq.

The Fludeoxyglucose (FDG) is the widest used PET imaging agent in oncology, for the detection of primary tumors, differential diagnosis, and characterization of residual tumors after treatment as well as for monitoring of chemotherapy. It is also used for the PET assessment of glucose metabolism in the heart, lung and brain.